[1] World Health Organization. Available: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b [Accessed 12 July 2023]. [2] Cao G, Liu J, Liu M. Trends in mortality of liver disease due to hepatitis B in China from 1990 to 2019: findings from the Global Burden of Disease Study [J]. Chin Med J (Engl),2022,135(17):2049-2055. [3] 中华医学会肝病学分会, 中华医学会感染病学分会. 慢性乙型肝炎防治指南(2022年版) [J]. 中华传染病杂志,2023,41(1):3-28. [4] Zhang Z Q, Shi BS, Lu W, et al. Quantitative Anti-HBc in Liver Pathological States in Patients with Chronic Hepatitis B Virus Infection [J]. Can J Infect Dis Med Microbiol,2019,2019:6545642. [5] Zhang ZQ, Shi BS, Lu W, et al. Quantitative serum HBV markers in predicting phases of natural history of chronic HBV infection [J]. J Virol Methods,2021,296:114226. [6] Scheuer PJ. The nomenclature of chronic hepatitis: time for a change [J]. J Hepatol,1995,22(1):112-114. [7] Xiao G, Yang J, Yan L. Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis [J]. Hepatology,2015,61(1):292-302. [8] Lemoine M, Shimakawa Y, Nayagam S, et al. The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa [J]. Gut,2016,65(8):1369-1376. [9] Li Q, Lu C, Li W, et al. The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease [J]. Oncotarget,2017,8(17):28641-28649. [10] Zhao XA, Wang J, Wei J, et al. Gamma-glutamyl Transpeptidase to Platelet Ratio Predicts Liver Injury in Hepatitis B e Antigen-negative Chronic Hepatitis B Patients With Normal Alanine Aminotransferase [J]. J Clin Transl Hepatol,2022,10(2):247-253. [11] Taefi A, Huang CC, Kolli K, et al. Red cell distribution width to platelet ratio, a useful indicator of liver fibrosis in chronic hepatitis patients [J]. Hepatol Int,2015,9(3):454-460. [12] Yao K, Wang J, Wang L, et al. Association of anti-HBc and liver inflammation in HBeAg-negative chronic hepatitis B virus-infected patients with normal ALT and detectable HBV DNA [J]. J Med Virol, 2022,94(2):659-666. [13] Chen S, Huang H, Huang W. A noninvasive model to predict liver histology for antiviral therapy decision in chronic hepatitis B with alanine aminotransferase < 2 upper limit of normal [J]. BMC Gastroenterol,2021,21(1):4. [14] Chauhan A, Adams DH, Watson SP, et al. Platelets: No longer bystanders in liver disease [J]. Hepatology,2016,64(5):1774-1784. [15] Ramadori P, Klag T, Malek NP, et al. Platelets in chronic liver disease, from bench to bedside [J]. JHEP Rep,2019,1(6):448-459. [16] Hutchinson DR, Smith MG. Serum "prealbumin" as an index of liver function in human hepatobiliary disease [J]. Clin Chim Acta,1981,114(1):69-74. [17] Rondana M, M L, Merkel C, et al. Value of prealbumin plasma levels as liver test [J]. Digestion,1987,37(2):72-78. [18] 陈立宇, 王娟, 王威亚, 等. 301例慢性乙型肝炎病毒感染者血清学指标与肝脏组织病理的相关性分析[J]. 四川大学学报(医学版) .2015,46(04):641-644. [19] 林广民. 肝硬化患者血清前白蛋白、胆碱酯酶含量检测及其与肝功能、肝纤维化程度的相关性研究[J]. 肝脏.2018,23(4):323-325. [20] Liu D, Li J, Lu W, et al. Gamma-glutamyl transpeptidase to cholinesterase and platelet ratio in predicting significant liver fibrosis and cirrhosis of chronic hepatitis B [J]. Clin Microbiol Infect,2019,25(4):514 e1-e8. [21] 朱琪, 刘银环, 程变巧, 等. 慢性乙型肝炎病毒携带者肝纤维化的相关因素分析[J]. 厦门大学学报(自然科学版).2021,60(5):912-916. |